These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19796414)

  • 1. Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution.
    Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
    Respir Care; 2009 Oct; 54(10):1342-7. PubMed ID: 19796414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of aerosol output from various nebulizer/compressor combinations.
    Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS
    Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation of compressor/nebulizer performance.
    Awad S; Williams DK; Berlinski A
    Respir Care; 2014 Jul; 59(7):1053-61. PubMed ID: 24149670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulator.
    Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
    Respir Care; 2009 Nov; 54(11):1488-92. PubMed ID: 19863833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type.
    Okapo SO; Gupta J; Martinez E; Mark R
    Curr Med Res Opin; 2009 Apr; 25(4):807-16. PubMed ID: 19207092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of positive expiratory pressure devices attached to nebulizers.
    Berlinski A
    Respir Care; 2014 Feb; 59(2):216-22. PubMed ID: 23920213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
    Hunke WA; Yu AB
    Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro analysis of the output of salbutamol from different nebulizers.
    Barry PW; O'Callaghan C
    Eur Respir J; 1999 May; 13(5):1164-9. PubMed ID: 10414421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients.
    Awad SM; Berlinski A
    Respir Care; 2018 Mar; 63(3):294-300. PubMed ID: 29432139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy.
    Berlinski A
    Respir Care; 2013 Dec; 58(12):2076-86. PubMed ID: 23674810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
    Berg EB; Picard RJ
    Respir Care; 2009 Dec; 54(12):1671-8. PubMed ID: 19961633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
    Johnson JC; Waldrep JC; Guo J; Dhand R
    Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
    Kwong WT; Ho SL; Coates AL
    J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study.
    Van Dyke RE; Nikander K
    Respir Care; 2007 Feb; 52(2):184-90. PubMed ID: 17261207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent.
    Mitchell JP; Nagel MW; Bates SL; Doyle CC
    Respir Care; 2003 Jan; 48(1):46-51. PubMed ID: 12556261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor.
    Westerman EM; Boer AH; Touw DJ; Brun PP; Roldaan AC; Frijlink HW; Heijerman HG
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):269-80. PubMed ID: 18759658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.